secwatch.observer — SEC 8-K summary
======================================

Issuer:     Applied UV, Inc. (—)
CIK:        0001811109
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0001213900-24-044796
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Applied UV receives Nasdaq delisting notice for Audit Committee non-compliance
------------------------------------------------------------------------------

- Notice dated May 15, 2024: Audit Committee now has only 2 independent directors after Eugene Burleson's resignation.
- Cure period until earlier of next annual meeting or May 7, 2025; if annual meeting before Nov 4, 2024, compliance by Nov 4, 2024.
- Company intends to elect one independent director to fill Audit Committee vacancy.
- Appointed Christopher Kochuba to Audit and Compensation Committees effective May 14, 2024.
- No immediate effect on listing or trading of AUVI or AUVIP on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811109/000121390024044796/0001213900-24-044796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811109/000121390024044796/ea0206315-8k_applied.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-044796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer